[Rocky Mountain spotted fever in Mexican children: Clinical and mortality factors]
Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases
Published on: December 15, 2023
Insights
Rocky Mountain spotted fever (RMSF) has a high fatality rate in children. Timely doxycycline treatment, avoiding delays, and managing acute renal failure and severe sepsis can improve outcomes for pediatric RMSF patients.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Clinical Medicine
Background:
- Rocky Mountain spotted fever (RMSF) poses a significant threat to children's health.
- Understanding clinical manifestations and mortality predictors is crucial for effective management.
Purpose of the Study:
- To characterize clinical features of pediatric RMSF.
- To identify predictors of mortality in hospitalized children with RMSF.
Main Methods:
- A cross-sectional study was conducted involving 210 pediatric patients diagnosed with RMSF.
- Data were collected from January 2004 to June 2015 in Sonora, Mexico.
- Statistical analysis included descriptive statistics and multivariate logistic regression.
Main Results:
- An increasing trend in RMSF morbidity and mortality was observed.
- The overall fatality rate was 30%.
- Key predictors of death included delayed doxycycline treatment (≥ 5 days), acute renal failure, and severe sepsis.
Conclusions:
- RMSF is associated with high mortality in pediatric populations.
- Prompt initiation of doxycycline treatment is vital for preventing fatalities.
- Acute renal failure and severe sepsis are independent predictors of mortality in children with RMSF.
Objective:
Characterize clinical manifestations and predictors of mortality in children hospitalized for spotted fever.
Materials And Methods:
Cross-sectional study in 210 subjects with a diagnosis of Rocky Mountain spotted fever (RMSF) in a pediatric hospital in Sonora, from January 1st, 2004 to June 30th, 2015. Data were analyzed using descriptive statistics and multivariate logistic regression.
Results:
An upward trend was observed in RMSF morbidity and mortality. Fatality rate was 30%.Three predictors were associated with risk of death: delay ≥ 5 days at the start of doxycycline (ORa= 2.95, 95% CI 1.10-7.95), acute renal failure ((ORa= 8.79, 95% CI 3.46-22.33) and severe sepsis (ORa= 3.71, 95% CI 1.44-9.58).
Conclusions:
RMSF causes high mortality in children, which can be avoided with timely initiation of doxycycline. Acute renal failure and severe sepsis are two independent predictors of death in children with RMSF.
Related Concept Videos
Fungal Phylum Microsporidia
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism

